Insilico Medicine vs Recursion Pharmaceuticals
Two Pharmaceuticals AI tools, side by side. Both are verified against their own live sites. Here is what each does well and who it is for, so you can choose what fits.
Insilico Medicine
insilico.com
Generative AI and automation for drug discovery and longevity
Best forPharma and biotech R&D teams running generative AI target discovery and small-molecule design programs
PricingEnterprise · current pricing
What it doesInsilico Medicine runs Pharma.ai, a suite of generative AI tools spanning target discovery (PandaOmics), small-molecule design (Chemistry42), biologics generation, and clinical trial outcome prediction (inClinico). The platform supports end-to-end discovery from biology through chemistry to clinical planning.
Capabilities
Visit Insilico Medicine →- Target identification via omics analysis (PandaOmics)
- Generative small-molecule design with ADMET and retrosynthesis (Chemistry42)
- Biologics generation
- Clinical trial outcome prediction (inClinico)
Recursion Pharmaceuticals
www.recursion.com
Decoding biology to improve lives
Best forOrganizations seeking AI-led target discovery and molecule optimization at industrial scale through partnership
PricingEnterprise · current pricing
What it doesRecursion operates the Recursion OS, an AI-driven drug discovery platform combining large proprietary biological and chemical datasets, automated wet-lab experimentation, and machine learning models to identify novel targets and design optimized molecules. The platform supports oncology and rare-disease programs.
Capabilities
Visit Recursion Pharmaceuticals →- Phenomics and multi-omics data generation at scale
- Automated high-throughput cell experimentation
- Machine learning target identification
- Molecule design and optimization
How to choose
Choose Insilico Medicine if you are pharma and biotech r&d teams running generative ai target discovery and small-molecule design programs. Choose Recursion Pharmaceuticals if you are organizations seeking ai-led target discovery and molecule optimization at industrial scale through partnership. Both sit in Pharmaceuticals; the right pick depends on your exact workflow and budget.
Not sure which to pick?
Get our short, vendor-neutral AI briefing and we will help you choose well.
Double opt-in · unsubscribe any time